170 related articles for article (PubMed ID: 24980806)
121. Effects of P-glycoprotein inhibitors on cadmium accumulation in cultured renal epithelial cells, LLC-PK1, and OK.
Endo T; Kimura O; Sakata M
Toxicol Appl Pharmacol; 2002 Dec; 185(3):166-71. PubMed ID: 12498733
[TBL] [Abstract][Full Text] [Related]
122. Comparative studies on in vitro methods for evaluating in vivo function of MDR1 P-glycoprotein.
Adachi Y; Suzuki H; Sugiyama Y
Pharm Res; 2001 Dec; 18(12):1660-8. PubMed ID: 11785684
[TBL] [Abstract][Full Text] [Related]
123. Abcb1 in Pigs: Molecular cloning, tissues distribution, functional analysis, and its effect on pharmacokinetics of enrofloxacin.
Guo T; Huang J; Zhang H; Dong L; Guo D; Guo L; He F; Bhutto ZA; Wang L
Sci Rep; 2016 Aug; 6():32244. PubMed ID: 27572343
[TBL] [Abstract][Full Text] [Related]
124. The Blood-Brain Barrier Permeability of Six Indole Alkaloids from Uncariae Ramulus Cum Uncis in the MDCK-pHaMDR Cell Monolayer Model.
Zhang YN; Yang YF; Xu W; Yang XW
Molecules; 2017 Nov; 22(11):. PubMed ID: 29125571
[No Abstract] [Full Text] [Related]
125. 4-Substituted-2-phenylquinazolines as inhibitors of BCRP.
Juvale K; Wiese M
Bioorg Med Chem Lett; 2012 Nov; 22(21):6766-9. PubMed ID: 23017888
[TBL] [Abstract][Full Text] [Related]
126. Limited role of P-glycoprotein in the intestinal absorption of cyclosporin A.
Lee YJ; Chung SJ; Shim CK
Biol Pharm Bull; 2005 Apr; 28(4):760-3. PubMed ID: 15802827
[TBL] [Abstract][Full Text] [Related]
127. Polysorbate 20 alters the oral bioavailability of etoposide in wild type and mdr1a deficient Sprague-Dawley rats.
Al-Ali AAA; Quach JRC; Bundgaard C; Steffansen B; Holm R; Nielsen CU
Int J Pharm; 2018 May; 543(1-2):352-360. PubMed ID: 29635055
[TBL] [Abstract][Full Text] [Related]
128. ABCB1 1199G > A Polymorphism Impacts Transport Ability of P-gp-Mediated Antipsychotics.
Wang R; Sun X; Deng YS; Qiu XW
DNA Cell Biol; 2018 Apr; 37(4):325-329. PubMed ID: 29443543
[TBL] [Abstract][Full Text] [Related]
129. Evidence for a polarized efflux system in CACO-2 cells capable of modulating cyclosporin A transport.
Augustijns PF; Bradshaw TP; Gan LS; Hendren RW; Thakker DR
Biochem Biophys Res Commun; 1993 Dec; 197(2):360-5. PubMed ID: 7903526
[TBL] [Abstract][Full Text] [Related]
130. Preventive effects of two PAF-antagonists, PMS 536 and PMS 549, on cyclosporin-induced LLC-PK1 oxidative injury.
Massicot F; Lamouri A; Martin C; Pham-Huy C; Heymans F; Warnet JM; Godfroid JJ; Claude JR
J Lipid Mediat Cell Signal; 1997 Jan; 15(2):203-14. PubMed ID: 9034965
[TBL] [Abstract][Full Text] [Related]
131. Establishment and characterization of an MDCK cell line stably-transfected with chicken Abcb1 encoding P-glycoprotein.
Sun Y; Guo T; Guo D; Guo L; Chen L; Zhang Y; Wang L
Res Vet Sci; 2016 Jun; 106():37-44. PubMed ID: 27234533
[TBL] [Abstract][Full Text] [Related]
132. Role of P-glycoprotein in the brain disposition of seletalisib: Evaluation of the potential for drug-drug interactions.
Nicolas JM; Chanteux H; Nicolaï J; Brouta F; Viot D; Rosseels ML; Gillent E; Bonnaillie P; Mathy FX; Long J; Helmer E
Eur J Pharm Sci; 2020 Jan; 142():105122. PubMed ID: 31678424
[TBL] [Abstract][Full Text] [Related]
133. Energy transfer to analyse membrane-integrated mitoxantrone in BCRP-overexpressed cells.
Breuzard G; El-Khoury V; Millot C; Manfait M; Millot JM
J Photochem Photobiol B; 2007 May; 87(2):113-23. PubMed ID: 17433706
[TBL] [Abstract][Full Text] [Related]
134. Effect of cyclosporin A on nitric oxide production in cultured LLC-PK1 cells.
Lima R; Serone AP; Schor N; Higa EM
Ren Fail; 2001 Jan; 23(1):43-52. PubMed ID: 11256528
[TBL] [Abstract][Full Text] [Related]
135. Excipient-mediated alteration in drug bioavailability in the rat depends on the sex of the animal.
Mai Y; Afonso-Pereira F; Murdan S; Basit AW
Eur J Pharm Sci; 2017 Sep; 107():249-255. PubMed ID: 28709912
[TBL] [Abstract][Full Text] [Related]
136. In vivo evidence for ATP-dependent and P-glycoprotein-mediated transport of cyclosporin A at the blood-brain barrier.
Sakata A; Tamai I; Kawazu K; Deguchi Y; Ohnishi T; Saheki A; Tsuji A
Biochem Pharmacol; 1994 Nov; 48(10):1989-92. PubMed ID: 7986214
[TBL] [Abstract][Full Text] [Related]
137. Inhibitory effects of flavonoids on P-glycoprotein in vitro and in vivo: Food/herb-drug interactions and structure-activity relationships.
Bai J; Zhao S; Fan X; Chen Y; Zou X; Hu M; Wang B; Jin J; Wang X; Hu J; Zhang D; Li Y
Toxicol Appl Pharmacol; 2019 Apr; 369():49-59. PubMed ID: 30790579
[TBL] [Abstract][Full Text] [Related]
138. A transcellular assay to assess the P-gp inhibition in early stage of drug development.
Taur JS; Schuck EL; Wong NY
Drug Metab Lett; 2012; 6(4):285-91. PubMed ID: 23879790
[TBL] [Abstract][Full Text] [Related]
139. Role of P-glycoprotein in regulating cilnidipine distribution to intact and ischemic brain.
Yano K; Takimoto S; Motegi T; Tomono T; Hagiwara M; Idota Y; Morimoto K; Takahara A; Ogihara T
Drug Metab Pharmacokinet; 2014; 29(3):254-8. PubMed ID: 24366438
[TBL] [Abstract][Full Text] [Related]
140. Surface plasmon resonance biosensor combined with lentiviral particle stabilization strategy for rapid and specific screening of P-Glycoprotein ligands.
Cao Y; Cao Y; Shi Y; Cai Y; Chen L; Wang D; Liu Y; Chen X; Zhu Z; Hong Z; Chai Y
Anal Bioanal Chem; 2021 Mar; 413(7):2021-2031. PubMed ID: 33528601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
